SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Steinwachs D, Allen JD, Barlow WE, et al. NIH State-of-the-Science Conference Statement: enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements. 2010; 27: 1-31.
  • 2
    American Cancer Society. Colorectal cancer early detection. http://www.cancer.org/acs/groups/cid/documents/webcontent/003170-pdf.pdf. Accessed November 9, 2010.
  • 3
    U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2008; 149: 627-637.
  • 4
    Klabunde CN, Lanier D, Meissner HI, Breslau ES, Brown ML. Improving colorectal cancer screening through research in primary care settings. Med Care. 2008; 46: S1-S4.
  • 5
    Meissner HI, Breen NL, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the US. Cancer Epidemiol Biomarkers Prev. 2006; 15: 389-394.
  • 6
    Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 2008; 17: 430-437.
  • 7
    Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racial/ethnically diverse primary care patients. Med Care. 2008; 46: S10-S16.
  • 8
    DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008; 23: 169-174.
  • 9
    Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ. Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med. 2007; 44: 452-458.
  • 10
    Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997; 45: 211-218.
  • 11
    Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC, III. Attitudes toward colorectal cancer screening tests: a survey of patients and physicians. Journal of General Internal Medicine 2001; 16: 822-830.
  • 12
    Powell AA, Burgess DJ, Vernon SW, et al. Colorectal cancer screening mode preferences among US veterans. Prev Med. 2009; 49: 442-448.
  • 13
    Schroy PC, III, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care. 2007; 13: 393-400.
  • 14
    Schroy PC, Emmons K, Peters E, et al. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 2010; 31: 93-107.
  • 15
    Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006; 96: 809-811.
  • 16
    Pignone MP, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999; 14: 432-437.
  • 17
    Ruffin MT, Fetters MD, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev Med. 2007; 45: 267-273.
  • 18
    Vernon SW, Bartholomew LK, McQueen A, et al. A randomized controlled trial of a tailored computer-delivered intervention to promote colorectal cancer screening: sometimes more is just the same. Ann Behav Med. 2011; 41: 284-299.
  • 19
    Smith RA, von Eschenbach A, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin. 2001; 51: 38-75.
  • 20
    Partin MR, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control. 2010; 21: 1357-1368.
  • 21
    Vernon SW, McQueen A. Colorectal cancer screening. In: Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R, eds. Psycho-oncology. 2nd ed. New York: Oxford University Press; 2010: 71-83.
  • 22
    Vernon SW, Meissner HI, Klabunde CN, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2004; 13: 898-905.
  • 23
    Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992; 45: 941-950.
  • 24
    Lantz PM, Janz NK, Fagerlin A, et al. Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res. 2005; 40: 745-767.
  • 25
    McQueen A, Tiro JA, Vernon SW. Construct validity and invariance of four factors associated with colorectal cancer screening across gender, race, and prior screening. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2231-2237.
  • 26
    Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000: 1-367.
  • 27
    Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med. 2009; 37: 8-16.
  • 28
    Ling BS, Schoen RE, Trauth JM, et al. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med. 2009; 169: 47-55.
  • 29
    McQueen A, Bartholomew LK, Greisinger AJ, et al. Behind closed doors: physician-patient discussions about colorectal cancer screening. J Gen Intern Med. 2009; 24: 1228-1235.
  • 30
    Lafata JE, Divine G, Moon C, Williams LK. Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med. 2006; 31: 202-209.